Ro 07-1902
Ro 07-1902 is an effective antitumor potentiator that can significantly enhance the antitumor effect of CCNU (HY-13669) against KHT sarcoma at low doses[1].
Product Specifications
CAS Number
[68160-71-4]
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ro-07-1902.html
Smiles
OC(CN1C=CN=C1[N+]([O-])=O)CO/C=C/C
Molecular Formula
C9H13N3O4
Molecular Weight
227.22
References & Citations
[1]Workman P, et al. Structure/activity relationships for the enhancement by electron-affinic drugs of the anti-tumour effect of CCNU. Br J Cancer. 1982 Aug;46 (2) :249-59.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1460834-01 0.02 mg (E-Coli)
Recombinant Bordetella avium 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details 
MBS1460834-02 0.02 mg (Yeast)
Recombinant Bordetella avium 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details 
MBS1460834-03 0.1 mg (E-Coli)
Recombinant Bordetella avium 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details MBS1460834-04 0.1 mg (Yeast)
Recombinant Bordetella avium 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details MBS1460834-05 0.02 mg (Baculovirus)
Recombinant Bordetella avium 2-dehydro-3-deoxyphosphooctonate aldolase (kdsA)
Ask
View Details